<document id="DDI-DrugBank.d599">
    <sentence id="DDI-DrugBank.d599.s0" text="Excessive glucocorticoid therapy will inhibit the growth-promoting effect of human GH. ">
        <entity charOffset="77-84" id="DDI-DrugBank.d599.s0.e0" text="human GH" type="drug" />
    </sentence>
    <sentence id="DDI-DrugBank.d599.s1" text="Patients with ACTH deficiency should have their glucocorticoid-replacement dose carefully adjusted to avoid an inhibitory effect on growth. ">
        <entity charOffset="48-61" id="DDI-DrugBank.d599.s1.e0" text="glucocorticoid" type="group" />
    </sentence>
    <sentence id="DDI-DrugBank.d599.s2" text="The use of Nutropin in patients with chronic renal insufficiency receiving glucocorticoid therapy has not been evaluated. ">
        <entity charOffset="11-18" id="DDI-DrugBank.d599.s2.e0" text="Nutropin" type="brand" />
    </sentence>
    <sentence id="DDI-DrugBank.d599.s3" text="Concomitant glucocorticoid therapy may inhibit the growth-promoting effect of Nutropin. ">
        <entity charOffset="78-85" id="DDI-DrugBank.d599.s3.e0" text="Nutropin" type="brand" />
    </sentence>
    <sentence id="DDI-DrugBank.d599.s4" text="If glucocorticoid replacement is required, the glucocorticoid dose should be carefully adjusted. ">
        <entity charOffset="3-16" id="DDI-DrugBank.d599.s4.e0" text="glucocorticoid" type="group" />
        <entity charOffset="47-60" id="DDI-DrugBank.d599.s4.e1" text="glucocorticoid" type="group" />
        <pair ddi="false" e1="DDI-DrugBank.d599.s4.e0" e2="DDI-DrugBank.d599.s4.e1" id="DDI-DrugBank.d599.s4.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d599.s5" text="There was no evidence in the controlled studies of Nutropin   s interaction with drugs commonly used in chronic renal insufficiency patients. ">
        <entity charOffset="51-58" id="DDI-DrugBank.d599.s5.e0" text="Nutropin" type="brand" />
    </sentence>
    <sentence id="DDI-DrugBank.d599.s6" text="Limited published data indicate that GH treatment increases cytochrome P450 (CP450) mediated antipyrine clearance in man. ">
        <entity charOffset="37-38" id="DDI-DrugBank.d599.s6.e0" text="GH" type="drug" />
        <entity charOffset="93-102" id="DDI-DrugBank.d599.s6.e1" text="antipyrine" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d599.s6.e0" e2="DDI-DrugBank.d599.s6.e1" id="DDI-DrugBank.d599.s6.p0" type="mechanism" />
    </sentence>
    <sentence id="DDI-DrugBank.d599.s8" text="Careful monitoring is advisable when GH is administered in combination with other drugs known to be metabolized by CP450 liver enzymes.">
        <entity charOffset="37-38" id="DDI-DrugBank.d599.s8.e0" text="GH" type="drug" />
    </sentence>
</document>